Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM

Bone Marrow Transplantation, Published online: 21 February 2024; doi:10.1038/s41409-024-02227-0Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM
Source: Bone Marrow Transplantation - Category: Hematology Authors: Source Type: research